4Schule C, Baghai TC, Rupprecht R. New insights into the pathogenesis and pathophysiology of depression [ J ]. Nervenarzt, 2007, 78(3) : 531 -547.
5Sanacora G, Saricicek A. GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action[J]. CNS Neurol Disord Drug Targets, 2007, 6(2) : 127 - 140.
6Sartorius A, Mahlstedt MM, Voilmayr B, et al. Elevated spectroscopic glutamate/gamma-amino butyric acid in rats bred for learned helplessness[ J]. Neuroreport, 2007, 18 (14) : 1469 - 1473.
7Willner P. Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm ease[ J]. Prog Nenropsyopharmacol Biol Psychiatry, 1986, 10(6) : 677 -690.
8Papp M, Gruca P, Bover PA, et al. Effect of agomelatine in the chronic mild stress model of depression in the rat [ J ]. Neuropsychopharmacology, 2003, 28 (4) : 694 - 703.
9Dai H, Fu Q, Shen Y. The histamine H3 receptor antagonist clobenpropit enhances GABA release toprotect against NMDA - induced excitotoxieity through the cAMP/protein kinase A pathway in cultured cortical neurons [ J ]. Eur J Pharmacol, 2007, 563 ( 1 - 3) : 117 - 123.
10Kugaya A, Sanacora G. Beyond monoamines: glutamatergic function in mood disorders[J]. CNS Spectr, 2005, 10(10) : 808 -819.
8Philipsen A,Limberger MF,Lieb K,et al.Attention-deficit hyperactivity disorder as a potentially aggravation factor in borderline personality disorder[J].Br J Psychiatry,2008,192(2):118-123.
9Wang Y,Zhu X,Yao S,et al.Screening cluster A and cluster B personality disorders in Chinese high school students[J].BMC Psychiatry,2013,13:116.
10Johnson JG,Cohen P,Brown J,et al.Childhood maltreatment increases risk for personality disorders during early adulthood[J].Arch Gen Psychiatry,1999,56(7):600-606.